Rankings
▼
Calendar
CRON (Cronos Group Inc.) Stock Financials & Earnings | Market Cap Arena
CRON
Cronos Group Inc.
Mkt Cap
$983M
Healthcare
·
Drug Manufacturers - Specialty & Generic
·
🇨🇦 Canada
·
NASDAQ
Revenue (TTM)
$193M
Net Income (TTM)
-$9M
EPS (TTM)
-$0.02
Free Cash Flow (TTM)
$121,593
Gross Margin
32.5%
Op. Margin
-1.5%
Net Margin
-4.9%
FCF Margin
0.1%
P/S Ratio (TTM)
5.1x
P/E Ratio (TTM)
—
YoY Rev Growth
+64.4%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$19M
$3M
-$21M
Q2 23
$19M
$3M
-$21M
Q3 23
$25M
$4M
-$22M
Q4 23
$24M
$2M
-$22M
Q1 24
$25M
$4M
-$16M
Q2 24
$28M
$6M
-$16M
Q3 24
$34M
$4M
-$34M
Q4 24
$30M
$11M
-$11M
Q1 25
$32M
$14M
-$4M
Q2 25
$33M
$15M
-$5M
Q3 25
$36M
$18M
-$503K
Q4 25
$91M
$16M
$7M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
10.0x
—
Q2 23
11.0x
—
Q3 23
11.4x
—
Q4 23
11.3x
—
Q1 24
10.6x
—
Q2 24
9.7x
—
Q3 24
8.8x
—
Q4 24
8.4x
23.9x
Q1 25
7.9x
19.9x
Q2 25
7.5x
53.2x
Q3 25
7.4x
27.2x
Q4 25
5.1x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$48M
-$48M
Q2 23
-$12M
-$12M
Q3 23
-$183K
-$508K
Q4 23
$17M
$15M
Q1 24
-$2M
-$4M
Q2 24
$2M
$828K
Q3 24
$12M
$5M
Q4 24
$8M
$4M
Q1 25
-$2M
-$17M
Q2 25
$3M
-$1M
Q3 25
$13M
$9M
Q4 25
$12M
$10M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$804K
Q2 23
$502K
Q3 23
$325K
Q4 23
$2M
Q1 24
$2M
Q2 24
$916K
Q3 24
$7M
Q4 24
$4M
Q1 25
$15M
Q2 25
$4M
Q3 25
$5M
Q4 25
$2M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-31.3%
-40.9%
Q2 23
-31.6%
-34.3%
Q3 23
-12.0%
-29.4%
Q4 23
+4.5%
-23.4%
Q1 24
+29.7%
+2.4%
Q2 24
+46.0%
+9.3%
Q3 24
+38.1%
+45.8%
Q4 24
+26.7%
-8.5%
Q1 25
+27.6%
-11.9%
Q2 25
+20.5%
-10.5%
Q3 25
+6.1%
-45.8%
Q4 25
+201.3%
+102.4%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
13.1%
Q2 23
$2M
12.3%
Q3 23
$2M
7.9%
Q4 23
$2M
8.1%
Q1 24
$2M
8.0%
Q2 24
$2M
8.1%
Q3 24
$2M
6.6%
Q4 24
$2M
7.2%
Q1 25
$2M
6.5%
Q2 25
$1M
4.1%
Q3 25
$2M
6.4%
Q4 25
-$6M
-6.4%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$2M
$14M
$6M
Q2 23
$1M
$16M
$5M
Q3 23
$1M
$16M
$5M
Q4 23
$1M
$12M
$6M
Q1 24
$997K
$11M
$5M
Q2 24
$962K
$15M
$4M
Q3 24
$1M
$15M
$6M
Q4 24
$1M
$14M
$6M
Q1 25
$793K
$11M
$5M
Q2 25
$929K
$12M
$5M
Q3 25
$1M
$12M
$5M
Q4 25
$1M
$7M
$7M
marketcaparena.com
Revenue Segments
Cannabis Extracts
Cannabis Flower
Product and Service, Other
Quarter
Cannabis Extracts
Cannabis Flower
Product and Service, Other
Q1 23
$7M
$13M
$66K
Q2 23
$5M
$14M
$81K
Q3 23
$7M
$17M
$128K
Q4 23
$5M
$18M
$327K
Q1 24
$8M
$18M
$36K
Q1 25
$9M
$23M
$310K
Q2 25
$8M
$25M
$70K
Q3 25
$10M
$26M
$13K
marketcaparena.com
Revenue by Geography
Canada
Israel
United States
Other Countries
Quarter
Canada
Israel
United States
Other Countries
Q1 23
$14M
$5M
$649K
—
Q2 23
$14M
$5M
—
—
Q3 23
$19M
$6M
—
$399K
Q4 23
$18M
$5M
—
$1M
Q1 24
$19M
$6M
—
—
Q1 25
$20M
$9M
—
$3M
Q2 25
$19M
$9M
—
$5M
Q3 25
$23M
$11M
—
$2M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$414M
$423M
$836M
Q2 23
$542M
$572M
$1.1B
Q3 23
$776M
$364M
$1.1B
Q4 23
$669M
$192M
$862M
Q1 24
$855M
$0
$855M
Q2 24
$848M
$0
$848M
Q3 24
$862M
$0
$862M
Q4 24
$859M
$0
$859M
Q1 25
$798M
$40M
$838M
Q2 25
$794M
$40M
$834M
Q3 25
$784M
$40M
$824M
Q4 25
$792M
$40M
$832M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
381M
+0.5%
Q2 23
381M
+0.1%
Q3 23
381M
+0.0%
Q4 23
381M
+0.0%
Q1 24
381M
+0.1%
Q2 24
382M
+0.2%
Q3 24
386M
+1.0%
Q4 24
387M
+0.1%
Q1 25
387M
+0.1%
Q2 25
385M
-0.4%
Q3 25
385M
+0.0%
Q4 25
385M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 20
$70K
665
FY 21
$103K
626
FY 22
$194K
447
FY 23
$245K
356
FY 24
$256K
459
FY 25
$317K
610
marketcaparena.com